Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now official registry

Safety Issues clinical trials

Every US clinical trial registered for Safety Issues — phase mix, recruiting status, and the sponsors running them, straight from the NIH ClinicalTrials.gov registry.

14 US clinical trials · 2 currently recruiting

The research picture

Safety Issues has 14 registered US clinical trials, 2 of them open to new participants right now — about 14% of the total.

2
recruiting participants now
14%
of trials open to enrollment
0
in Phase 3–4 (later-stage)
1
top sponsor: International Partnership for Microbicides

Counts reflect the public ClinicalTrials.gov registry as last mirrored by PlainTrial. Status and phase are reported by each study's sponsor. This is reference information, not medical advice.

Active & Recent Trials

RECRUITING NA 400 participants

BeSMART Secure Storage Counseling in the Inpatient Setting

Vanderbilt University Medical Center

NCT06485141

RECRUITING Phase 1 196 participants

Phase1/2a Study for IPG7236 in Patients With Advanced Solid Tumors

Nanjing Immunophage Biotech Co.

NCT05142592

ACTIVE NOT RECRUITING Phase 1 32 participants

Role of a CCK Receptor Antagonist Proglumide in Management of Chronic Pancreatitis

Georgetown University

NCT05551858

ACTIVE NOT RECRUITING NA 28 participants

Directed Use of REmote Patient Management System AMia to Achieve Prescribed Dry Weight

University of California, San Diego

NCT04002440

ACTIVE NOT RECRUITING Phase 1 13 participants

A Phase 1 Study of the Safety and Tolerability of ICM20 in Adults

IC-MedTech Corporation

NCT05523596

COMPLETED 674 participants

Survey of Housestaff Attitudes Toward Patient Care and Safety

Weill Medical College of Cornell University

NCT00845052

COMPLETED NA 56 participants

Assessing the Effects of a Cannabidiol Derived From Hemp Supplement in Healthy Adults

University of South Carolina

NCT05212402

COMPLETED Phase 1 40 participants

PK, Safety Study of 90-Day Use of Vaginal Rings Containing Dapivirine and Levonorgestrel

International Partnership for Microbicides

NCT05041699

COMPLETED NA 30 participants

Buck Institute Ketone Ester RCT

Buck Institute for Research on Aging

NCT05585762

COMPLETED Phase 1 24 participants

A Phase 1 Study of EXT608 in Healthy Adults

Extend Biosciences

NCT05408663

COMPLETED Phase 1 21 participants

Rectal Insert TAF/EVG Pre-Exposure Prophylaxis (RITE PrEP) Study

Eastern Virginia Medical School

NCT06274398

COMPLETED Phase 1 21 participants

Oral Remimazolam With and Without Alcohol in Healthy Female Subjects

Paion UK

NCT04113343

COMPLETED Phase 1 20 participants

Pupillary Unrest in Ambient Light, and Relationship to Opioid-Induced Respiratory Depression

University of California, San Francis

NCT04301895

COMPLETED NA 1 participants

Effect of Naringenin and Beta Carotene on Energy Expenditure

Pennington Biomedical Research Center

NCT04697355

Phase Distribution

PhaseTrial count
Phase 1 8

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Reading the Safety Issues Trial Landscape

ClinicalTrials.gov lists 14 US studies indexed under Safety Issues, and 2 of those are currently open to recruitment — roughly 14% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.

The phase distribution for Safety Issues shows 0 late-stage studies (Phase 3 and Phase 4 combined) alongside 8 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.

Top sponsor activity for Safety Issues is led by International Partnership for Microbicides with 1 indexed trial, alongside 9 other organizations in the top contributor list. The list on this page surfaces up to 14 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.

Frequently Asked Questions

How many clinical trials are there for Safety Issues?

PlainTrial tracks 14 US clinical trials for Safety Issues, of which 2 are currently recruiting participants. Data sourced from ClinicalTrials.gov.

How do I find a recruiting trial for Safety Issues?

Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.

Is this data current?

Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.

Related

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.

Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.

Verify with NIH →